Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Estrogen-related receptor alpha (ERRα), also known as ESRRA or NR3B1, is an orphan nuclear receptor that plays a central role in regulating cellular metabolism, particularly in tissues with high energy demands such as cardiac and skeletal muscle. Despite its structural similarity to classical estrogen receptors, ERRα does not bind estrogens with high affinity and has no well-established endogenous ligand. ERRα acts primarily as a transcription factor, binding specific DNA sequences to regulate genes involved in mitochondrial biogenesis, oxidative phosphorylation, and fatty acid oxidation. It is predominantly expressed in metabolically active tissues like the heart, skeletal muscle, and brown adipose tissue and is implicated in diseases such as cancer, insulin resistance, and NAFLD.
Binds to specific DNA sequences (TNAAGGTCA) to regulate gene expression; interacts with PGC-1α to enhance mitochondrial function and metabolic regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Estrogen-related receptor alpha (ERRα).